ANI Launches Erythromycin Ethylsuccinate for Oral Suspension

Erythromycin Ethylsuccinate for Oral Suspension is available as a 200mg/5mL strength.
Erythromycin Ethylsuccinate for Oral Suspension is available as a 200mg/5mL strength.

ANI announced the launch of Erythromycin Ethylsuccinate for Oral Suspension, the generic version of Arbor'Eryped and E.E.S

Erythromycin Ethylsuccinate for Oral Suspension is indicated for the treatment of susceptible infections including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires' disease, pertussis, and listeriosis. Erythromycin Ethylsuccinate is an oral macrolide that acts by inhibition of protein synthesis through binding 50S ribosomal subunits of susceptible organisms. It does not affect nucleic acid synthesis. 

Related Articles

Erythromycin Ethylsuccinate for Oral Suspension is available as a 200mg/5mL strength. 

For more information call (800) 434-1121 or visit ANIpharmaceuticals.com.

Loading links....